Childhood-onset systemic lupus erythematosus in croatia: Demographic, clinical and laboratory features, and factors influencing time to diagnosis

Clinical and Experimental Rheumatology

Volumn 31, Issue 5, 2013, Pages 0803-0812

  Lukić, Anita ^a,b   Malčić, Ivan ^a   Batinić, Danica ^a   Milošević, Danko ^a   Rožmanić, Vojko ^d   Saraga, Marijan ^c   Šubat Dežulović, Mirna ^d   Metličić, Vitomir ^c   Lukić, Ivan Krešimir ^c   Malenica, Branko ^a   Jelušić, Marija ^a  

^a KBC Zagreb   (Croatia)

^b Varazdin General Hospital   (Croatia)

^c UNIVERSITY HOSPITAL SPLIT   (Croatia)

^d KBC RIJEKA   (Croatia)

Author keywords

Childhood onset systemic lupus erythemathosus; Croatia; Factors influencing time to diagnosis; Incidence

Indexed keywords

AZATHIOPRINE; CD20 ANTIBODY; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; CREATININE; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA; GLUCOCORTICOID; HISTONE ANTIBODY; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOMODULATING AGENT; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROATIA; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENVIRONMENTAL FACTOR; ERYTHROCYTE COUNT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GLOMERULONEPHRITIS; HUMAN; HUMAN TISSUE; INCIDENCE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; ONSET AGE; OUTCOME ASSESSMENT; PATHOGENESIS; PERICARDIOCENTESIS; PLASMAPHERESIS; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SUNLIGHT; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; BLOOD; CHI SQUARE DISTRIBUTION; DELAYED DIAGNOSIS; IMMUNOLOGY; MULTICENTER STUDY; PREDICTIVE VALUE; TERTIARY CARE CENTER; TIME; CLINICAL TRIAL; LUPUS ERYTHEMATOSUS, SYSTEMIC;

ADOLESCENT; AGE OF ONSET; CHI-SQUARE DISTRIBUTION; CHILD; CROATIA; DELAYED DIAGNOSIS; FEMALE; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS; TIME FACTORS;

EID: 84884957737     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. PETTY RE, LAXER RM: Systemic lupus erythematosus. In CASSIDY JT, PETTY RE (Eds.): Textbook of Pediatric Rheumatology. Pensylvania, WB Saunders 2005: 342-391.
2. BERTOLI AM, ALARCON GS: Epidemiology and diagnosis. In TSOKOS GC, GORDON C, SMOLEN JS (Eds.): Systemic Lupus Erythematosus: A Companion to Rheumatology. Philadelphia, Mosby 2007: 6.
3. BADER-MEUNIER B, ARMENGAUD JB, HADDAD E et al.: Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr 2005; 146: 648-53.
4. KLEIN-GITELMAN M, REIFF A, SILVERMAN ED: Systemic lupus erythematosus in childhood. Rheum Dis Clin North Am 2002; 28: 561-77, vi-vii.
5. HIRAKI LT, FELDMAN CH, LIU J et al.: Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum 2012; 64: 2669-76.
6. KAIPIAINEN-SEPPÄNEN O, SAVOLAINEN A: Incidence of chronic juvenile rheumatic diseases in Finland during 1980-1990. Clin Exp Rheumatol 1996; 14: 441-4.
7. MALLESON PN, FUNG MY, ROSENBERG AM: The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association Disease Registry. J Rheumatol 1996; 23: 1981-7.
8. FALLER G, THOMSON PD, KALA UK, HAHN D: Demographics and presenting clinical features of childhood systemic lupus erythematosus. S Afr Med J 2005; 95: 424-7.
9. HOCHBERG MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
10. RAVELLI A, DUARTE-SALAZAR C, BURATTI S et al.: Assessment of damage in juvenileonset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum 2003; 49: 501-7.
11. RUPERTO N, BURATTI S, DUARTE-SALAZAR C et al.: Health-related quality of life in juvenile- onset systemic lupus erythematosus and its relationship to disease activity and damage. Arthritis Rheum 2004; 51: 458-64.
12. HUANG JL, LIN CJ, HUNG IJ, LUO SF: The morbidity and mortality associated with childhood onset systemic lupus erythematosus. Changgeng Yi Xue Za Zhi 1994; 17: 113-20.
13. RAVELLI A, LATTANZI B, CONSOLARO A, MARTINI A: Glucocorticoids in paediatric rheumatology. Clin Exp Rheumatol 2011; 29 (Suppl 68): S148-52.
14. BRUNNER HI, GLADMAN DD, IBAÑEZ D, UROWITZ MD, SILVERMAN ED: Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 2008; 58: 556-62.
15. RAVELLI A, RUPERTO N, MARTINI A: Outcome in juvenile onset systemic lupus erythematosus. Curr Opin Rheumatol 2005; 17: 568-73.
16. VITALI C, BENCIVELLI W, ISENBERG DA et al.: Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992; 10: 541-7.
17. MOSCA M, BENCIVELLI W, VITALI C, CARRAI P, NERI R, BOMBARDIERI S: The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus. Lupus 2000; 9: 445-50.
18. CHURG J, BERNSTEIN J, GLASSOCK RJ (Eds.): Classification and Atlas of Glomerular Disease. New York, Igaku-Shoin 1995: 51.
19. WEENING JJ, D'AGATI VD, SCHWARTZ MM et al.: The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15: 241-50.
20. ZANINOVIC K, GAJIC-CAPKA M, PERCEC TADIC M (Eds.): Climate atlas of Croatia 1961-1990., and 1971-2000. Zagreb, Meteorological and Hydrological Service of Croatia 2008.
21. HIRAKI LT, BENSELER SM, TYRRELL PN, HEBERT D, HARVEY E, SILVERMAN ED: Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr 2008; 152: 550-6.
22. FONT J, CERVERA R, ESPINOSA G et al.: Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 1998; 57: 456-9.
23. MORADINEJAD MH, ZAMANI GR, KIANI AR, ESFAHANI T: Clinical features of juvenile lupus erythematosus in Iranian children. Acta Reumatol Port 2008; 33: 63-7.
24. SMITH E, TAYLOR-ROBINSON D, GRAY W, FOSTER HE, BERESFORD MW: Predictors of access to care in JSLE - evidence form UJ JSLE Cohort Study. Ann Rheum Dis 2012; 71 (Suppl. 3): 676.
25. BURGOS PI, MCGWIN G JR, PONS-ESTEL GJ, REVEILLE JD, ALARCÓN GS, VILá LM: US patients of Hispanic and African ancestry develop lupus nephritis early in the disease course: data from LUMINA, a multiethnic US cohort (LUMINA LXXIV). Ann Rheum Dis 2011; 70: 393-4.
26. BURGOS PI, PERKINS EL, PONS-ESTEL GJ et al.: Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: data from a single US institution. Arthritis Rheum 2009; 60: 2757-66.
27. RICHMAN IB, TAYLOR KE, CHUNG SA et al.: European genetic ancestry is associated with a decreased risk of lupus nephritis. Arthritis Rheum 2012; 64: 3374-82.
28. HUI-YUEN JS, IMUNDO LF, AVITABILE C, KAHN PJ, EICHENFIELD AH, LEVY DM: Early versus later onset childhood-onset systemic lupus erythematosus: Clinical features, treatment and outcome. Lupus 2011: 20: 952-9.
29. APPENZELLER S, MARINI R, COSTALLAT LT: Damage did not independently influence mortality in childhood systemic lupus erythematosus. Rheumatol Int 2005; 25: 619-24.
30. Al-MOSAWI Z, Al-HERMI BE, Al-SAAD KK, FARID EM, MAKKI HA: Juvenile systemic lupus erythematosus in Bahrain. A tertiary referral center experience. Saudi Med J 2009; 30: 667-72.
31. GULAY CB, DANS LF: Clinical presentations and outcomes of Filipino juvenile systemic lupus erythematosus. Pediatr Rheumatol Online J 2011; 9: 7.
32. HOFFMAN IE, LAUWERYS BR, de KEYSER F et al.: Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Ann Rheum Dis 2009; 68: 412-5.
33. BAKR A: Epidemiology treatment and outcome of childhood systemic lupus erythematosus in Egypt. Pediatr Nephrol 2005; 20: 1081-6.
34. ABDWANI R, RIZVI SG, El-NOUR I: Childhood systemic lupus erythematosus in Sultanate of Oman: demographics and clinical analysis. Lupus 2008; 17: 683-6.
35. AGMON-LEVIN N, MOSCA M, PETRI M, SHOENFELD Y: Systemic lupus erythematosus one disease or many?. Autoimmun Rev 2012; 11: 593-5.
36. AIKAWA NE, JESUS AA, LIPHAUS BL et al.: Organ-specific autoantibodies and autoimmune diseases in juvenile systemic lupus erythematosus and juvenile dermatomyositis patients. Clin Exp Rheumatol 2012; 30: 126- 31.
37. FILOCAMO G, CONSOLARO A, SCHIAPPAPIETRA B et al.: A new approach to clinical care of juvenile idiopathic arthritis: the Juvenile Arthritis Multidimensional Assessment Report. J Rheumatol 2011; 38: 938-53.
38. ISENBERG DA, RAHMAN A, ALLEN E et al.: BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford) 2005; 44: 902-6.
39. BOMBARDIER C, GLADMAN DD, UROWITZ MB, CARON D, CHANG CH: Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-40.
40. WAGNER-WEINER L: Laboratory evaluation of children with rheumatic disease. Pediatr Ann 2002; 31: 362-371.
41. BREDA L, NOZZI E, DE SANCTIS S, CHIARELLI F: Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update. Semin arthritis Rheum 2010; 40: 53- 72.
42. TOZZOLI R: Recent advances in diagnostic technologies and their impact in autoimmune diseases. Autoimmun Rev 2007; 6: 334-340.